Study on the biological characteristics of Prokineticin 2 in circulation in obese children

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000038838

Enrollment

Unknown

Registered

2020-10-05

Start date

2020-10-10

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Obesity

Interventions

Normal weight group vs obese group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The control subjects were selected from routine medical check-up at the Department of Physical Examination Center. The obese children was defined as body mass index (BMI) greater than the 95th percentile of the appropriate age and gender, according to BMI growth reference for Chinese children aged 0-18 years.

Exclusion criteria

Exclusion criteria: Genetic or endocrine obesity; using metabolic drugs such as thyroxine tablets, dexamethasone, metaformin; hepatic or renal disease; cancers; recent infection; any medical or mental disease that would interfere with the study participation.

Design outcomes

Primary

Measure	Time frame
Height;Weight;Glucose;Insulin;triglyceride;total cholesterol;high-density lipoprotein;low-density lipoprotein;prokineticin 2;interleukin-6;tumor necrosis factor-a;	—

Countries

China

Contacts

Public ContactHan Wang

Children's Hospital of Chongqing Medical University

wanghanberyl@163.com+86 18323187902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026